Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS, SPINRAZA for the treatment of SMA, ADUHELM for the treatment of Alzheimer's disease, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.
Xiamen Maternal and Child Health Hospital, Xiamen, Fujian, China
The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China
Anhui Children's Hospital, Hefei, Anhui, China
Pharmaron CPC, Baltimore, Maryland, United States
Research Site, Austin, Texas, United States
Swedish Medical Center, Seattle, Washington, United States
University of Cincinnati, Cincinnati, Ohio, United States
Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong, China
Lady Davis Carmel Medical Center, Haifa, Israel
Meir Medical Center, Kfar Saba, Israel
Rabin Medical Center, Petah Tikva, Israel
Anaheim Clinical Trials, LLC, Anaheim, California, United States
Qps-Mra, Llc, South Miami, Florida, United States
University of Rochester, Rochester, New York, United States
Hopital Lapeyronie, Montpellier Cedex 5, Herault, France
Centrum Badawcze Panaceum Agnieszka Brzezicka, Magdalena Lenkiewicz Sp. z o.o., Malbork, Poland
MICS Centrum Medyczne Warszawa, Warszawa, Poland
Emory University, Atlanta, Georgia, United States
Northwestern University, Chicago, Illinois, United States
Johns Hopkins Hospital, Baltimore, Maryland, United States
Research Site, Vila Nova de Gaia, Portugal